Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (161-170 of 10,653) with videos related to

Pageof 1,066
Sort By:
Current Pharmaceutical Design|October 7, 2017
Sexual Dysfunction in Epilepsy and the Role of Anti-Epileptic DrugsMahinda Yogarajah, Marco Mula
Current Pharmaceutical Design|March 10, 2018
Plant-produced Recombinant Influenza A Vaccines Based on the M2e PeptideEugenia S Mardanova, Nikolai V Ravin
Current Pharmaceutical Design|October 20, 2017
Neonatal Pain, Still Searching for the Optimal ApproachElizabeth Walter-Nicolet, Laurent Calvel, Geraldine Gazzo, et al.
Current Pharmaceutical Design|July 14, 2017
Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders. Part 3: Alternative TherapyAlexander N Orekhov, Ekaterina A Ivanova
Current Pharmaceutical Design|July 14, 2017
Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of TreatmentTheodora Katsila, George P Patrinos
Current Pharmaceutical Design|January 10, 2019
Three-Dimensional (3-D) Printing Technology Exploited for the Fabrication of Drug Delivery SystemsFarrukh Zeeshan, Thiagarajan Madheswaran, Manisha Pandey, et al.
Current Pharmaceutical Design|November 1, 2006
Membrane channels as therapeutic targetsJean-Claude Hervé
Current Pharmaceutical Design|November 1, 2006
Anaesthetic drugs: linking molecular actions to clinical effectsChristian Grasshoff, Berthold Drexler, Uwe Rudolph, et al.
Current Pharmaceutical Design|November 1, 2006
Functional genome and proteome analyses of cutaneous autoimmune diseasesJ Trcka, M Kunz
Current Pharmaceutical Design|November 1, 2006
Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?M Cemazar, M Golzio, G Sersa, et al.
Pageof 1,066

Showing results (161-170 of 10,653) with videos related to

Sort By:
Pageof 1,066
Current Pharmaceutical Design|October 7, 2017
Sexual Dysfunction in Epilepsy and the Role of Anti-Epileptic DrugsMahinda Yogarajah, Marco Mula
Current Pharmaceutical Design|March 10, 2018
Plant-produced Recombinant Influenza A Vaccines Based on the M2e PeptideEugenia S Mardanova, Nikolai V Ravin
Current Pharmaceutical Design|October 20, 2017
Neonatal Pain, Still Searching for the Optimal ApproachElizabeth Walter-Nicolet, Laurent Calvel, Geraldine Gazzo, et al.
Current Pharmaceutical Design|July 14, 2017
Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders. Part 3: Alternative TherapyAlexander N Orekhov, Ekaterina A Ivanova
Current Pharmaceutical Design|July 14, 2017
Editorial: (Pharmaco)Metabolomics in Drug Discovery and Individualisation of TreatmentTheodora Katsila, George P Patrinos
Current Pharmaceutical Design|January 10, 2019
Three-Dimensional (3-D) Printing Technology Exploited for the Fabrication of Drug Delivery SystemsFarrukh Zeeshan, Thiagarajan Madheswaran, Manisha Pandey, et al.
Current Pharmaceutical Design|November 1, 2006
Membrane channels as therapeutic targetsJean-Claude Hervé
Current Pharmaceutical Design|November 1, 2006
Anaesthetic drugs: linking molecular actions to clinical effectsChristian Grasshoff, Berthold Drexler, Uwe Rudolph, et al.
Current Pharmaceutical Design|November 1, 2006
Functional genome and proteome analyses of cutaneous autoimmune diseasesJ Trcka, M Kunz
Current Pharmaceutical Design|November 1, 2006
Electrically-assisted nucleic acids delivery to tissues in vivo: where do we stand?M Cemazar, M Golzio, G Sersa, et al.
Pageof 1,066